Last update 26 Jul 2025

ZSP1241

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
ZSP 1241, ZSP-1241
Target
FGFR4
Action
antagonists
Mechanism
FGFR4 antagonists(Fibroblast growth factor receptor 4 antagonists)
Therapeutic Areas
NeoplasmsDigestive System DisordersOther Diseases
Active Indication-
Inactive Indication
Advanced Malignant Solid NeoplasmBile Duct NeoplasmsColorectal Cancer+ [3]
Originator Organization
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
Active Organization-
Inactive Organization
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with ZSP1241
NCT03734926
/ Unknown statusPhase 1
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and Tolerability Study of ZSP1241 in Participants With Advanced Solid Tumors
100 Clinical Results associated with ZSP1241
Login to view more data
100 Translational Medicine associated with ZSP1241
Login to view more data
100 Patents (Medical) associated with ZSP1241
Login to view more data
100 Deals associated with ZSP1241
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Bile Duct NeoplasmsPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Colorectal CancerPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Esophageal CarcinomaPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Hepatocellular CarcinomaPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Stomach CancerPhase 1
China
Guangdong Zhongsheng Pharmaceutical Co., Ltd.Guangdong Zhongsheng Pharmaceutical Co., Ltd.
13 Nov 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free